ArticlePolymers2025
Development and Characterization of Effective Hemostatic Composites Based on Polyvinyl Alcohol/Kaolinite/Chitosan.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
In this study, hemolytically safe and antibacterial polyvinyl alcohol/kaolinite/chitosan (PVA/KAO/CS) hydrogels were obtained using the freeze-thaw method. The structure of the chemical bonds present in the developed hydrogels was investigated by Fourier transform infrared spectroscopy (FTIR). Scanning electron microscopy (SEM) and optical microscopy study results showed the morphological and structural characteristics of the hydrogels' surface. The thermal stability and phase transitions of the obtained hydrogel samples were determined by thermogravimetric analysis (TGA). Porosity, swelling, gel fractions, and mechanical properties were also examined. Biomedical properties of the samples were evaluated using in vitro and in vivo tests such as hemolytic activity, inhibition of protein denaturation, antimicrobial activity, and hemostatic activity. The obtained hydrogels demonstrated safe hemolytic activity, pronounced hemostatic activity, the ability to prevent thermal denaturation of albumin, as well as antimicrobial activity against Gram-positive bacteria
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.